ImmPort Study ID	PubMed	Study Title	PI	Biosample ID	Experiment ID	Cohort	Repository Accession	Type	Subtype	Biosample Name	Biosample Description	Species	Strain	Cancer Type	Tissue	Cell Type	Cell Line	Treatment
GSE53001	25231172	Subclone of resistant CT26 murine tumor shows high sensitivity to VA7 virotherapy: A novel system to study innate immunity and antigen dominance in oncolytic immuno-virotherapy	None	SRX387240	GSE53001	murine colorectal carcinoma	GSM1280019	Colorectal Adenocarcinoma	Colon Adenocarcinoma (COAD)	CT26WT-control-rep1	None	Mus musculus	CT26WT-control-rep1	Colorectal Adenocarcinoma	CT26WT tumor	None	None	None
GSE53001	25231172	Subclone of resistant CT26 murine tumor shows high sensitivity to VA7 virotherapy: A novel system to study innate immunity and antigen dominance in oncolytic immuno-virotherapy	None	SRX387241	GSE53001	murine colorectal carcinoma	GSM1280020	Colorectal Adenocarcinoma	Colon Adenocarcinoma (COAD)	CT26WT-control-rep2	None	Mus musculus	CT26WT-control-rep2	Colorectal Adenocarcinoma	CT26WT tumor	None	None	None
GSE53001	25231172	Subclone of resistant CT26 murine tumor shows high sensitivity to VA7 virotherapy: A novel system to study innate immunity and antigen dominance in oncolytic immuno-virotherapy	None	SRX387242	GSE53001	murine colorectal carcinoma	GSM1280021	Colorectal Adenocarcinoma	Colon Adenocarcinoma (COAD)	CT26WT-SFV-infected-rep1	None	Mus musculus	CT26WT-SFV-infected-rep1	Colorectal Adenocarcinoma	CT26WT tumor	None	None	None
GSE53001	25231172	Subclone of resistant CT26 murine tumor shows high sensitivity to VA7 virotherapy: A novel system to study innate immunity and antigen dominance in oncolytic immuno-virotherapy	None	SRX387243	GSE53001	murine colorectal carcinoma	GSM1280022	Colorectal Adenocarcinoma	Colon Adenocarcinoma (COAD)	CT26WT-SFV-infected-rep2	None	Mus musculus	CT26WT-SFV-infected-rep2	Colorectal Adenocarcinoma	CT26WT tumor	None	None	None
GSE53001	25231172	Subclone of resistant CT26 murine tumor shows high sensitivity to VA7 virotherapy: A novel system to study innate immunity and antigen dominance in oncolytic immuno-virotherapy	None	SRX387244	GSE53001	murine colorectal carcinoma	GSM1280023	Colorectal Adenocarcinoma	Colon Adenocarcinoma (COAD)	CT26LacZ-control-rep1	None	Mus musculus	CT26LacZ-control-rep1	Colorectal Adenocarcinoma	CT26LacZ tumor	None	None	None
GSE53001	25231172	Subclone of resistant CT26 murine tumor shows high sensitivity to VA7 virotherapy: A novel system to study innate immunity and antigen dominance in oncolytic immuno-virotherapy	None	SRX387245	GSE53001	murine colorectal carcinoma	GSM1280024	Colorectal Adenocarcinoma	Colon Adenocarcinoma (COAD)	CT26LacZ-control-rep2	None	Mus musculus	CT26LacZ-control-rep2	Colorectal Adenocarcinoma	CT26LacZ tumor	None	None	None
GSE53001	25231172	Subclone of resistant CT26 murine tumor shows high sensitivity to VA7 virotherapy: A novel system to study innate immunity and antigen dominance in oncolytic immuno-virotherapy	None	SRX387246	GSE53001	murine colorectal carcinoma	GSM1280025	Colorectal Adenocarcinoma	Colon Adenocarcinoma (COAD)	CT26LacZ-SFV-infected-rep1	None	Mus musculus	CT26LacZ-SFV-infected-rep1	Colorectal Adenocarcinoma	CT26LacZ tumor	None	None	None
GSE53001	25231172	Subclone of resistant CT26 murine tumor shows high sensitivity to VA7 virotherapy: A novel system to study innate immunity and antigen dominance in oncolytic immuno-virotherapy	None	SRX387247	GSE53001	murine colorectal carcinoma	GSM1280026	Colorectal Adenocarcinoma	Colon Adenocarcinoma (COAD)	CT26LacZ-SFV-infected-rep2	None	Mus musculus	CT26LacZ-SFV-infected-rep2	Colorectal Adenocarcinoma	CT26LacZ tumor	None	None	None
